Last $5.64 USD
Change Today +0.02 / 0.36%
Volume 157.7K
ENZ On Other Exchanges
Symbol
Exchange
New York
Munich
As of 4:15 PM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

527 Madison Avenue

New York, NY 10022

United States

Phone: 212-583-0100

Fax:

rostaglandins/Thromboxanes, Microarray Labeling, Multidrug Resistance, Natural Products/Antibiotics, Neuroscience, Nitric Oxide Pathway, Nuclear Receptors, Oxidative Stress, Protein Aggregation, Proteosome/Ubiquitin, Receptors, Signal Transduction, Stem Cell/Cell Differentiation, Stress Proteins/Heat Shock Proteins, Toxicology, TNF/TNF Receptor Superfamily, and Transcription Factors. Enzo Life Sciences is organized to promote and market its products and brands under its own name, building on a foundation of the brands it has acquired or developed: Enzo: The Enzo brand products and technologies are primarily focused in the areas of microarray analysis, gene regulation and gene modification. Patented Enzo technologies and products are main tools in non-radioactive gene and protein labeling. Alexis: The Alexis brand provides recognition in producing and commercializing reagents and as a source for a comprehensive panel of products in research areas including the fields of cell death, nitric oxide, and obesity/adipogenesis. Biomol International: The Biomol International brand provides recognition in the cellular biochemistry segment with an emphasis on areas related to protein post-translational modification. Assay Designs: The Assay Designs brand emphasizes its immunoassay development capability in the fields of inflammation, steroids and hormones, and cell signaling. Stressgen: The Stressgen brand is focused exclusively on the fields of the heat shock and cell stress. Clinical Laboratory Services The company operates a regional clinical laboratory that offers diagnostic services to the New York, New Jersey and eastern Pennsylvania medical communities. The company’s clinical laboratory testing is utilized by physicians as an essential element in the delivery of healthcare services. Physicians use laboratory tests to assist in the detection, diagnoses, evaluation, monitoring and treatment of diseases and other medical conditions. Clinical laboratory testing is categorized as clinical testing and anatomic pathology testing. The company offers a range of routine and esoteric clinical laboratory tests or procedures. These tests are frequently used in general patient care by physicians to establish or support a diagnosis, to monitor treatment or medication levels, or search for an otherwise undiagnosed condition. Strategy The company’s objective is to be a developer and provider of the tools, services, and diagnostic technologies used to study and identify disease at the molecular level and to be a provider of therapeutic platforms to manage specific diseases. Main elements of its strategy involving three separate platforms include its ability to: maximize its resources by collaborating with others in research and commercialization activities; apply biomedical research technology to the clinical diagnostics market; exploit marketing and distribution infrastructure; expand collaborations with major life sciences companies; apply technology to a variety of diseases mediated by cell signaling pathways, by the immune system, or, in advanced cases, gene therapy; and expand and protect intellectual property estate. Research and Development The company’s principal research and development efforts are directed toward developing new clinical research and diagnostic platforms, and selective expansion of its research product lines. In the year ended July 31, 2013, the company incurred a cost of approximately $3.9 million for research and development activities. Sales and Marketing The company markets the clinical laboratory services to a range of ordering physicians in the metro New York, New Jersey and eastern Pennsylvania region through its direct sales force who are supported by customer service and patient service representatives. Intellectual Property As of July 31, 2013, the company owned or licensed approximately 140 patents relating to products, methods and procedures resulting from its internal or sponsored research projects. Regulations The company’s business is and would continue to be subject to regulation under various state and federal environmental, safety and health la

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $5.64 USD +0.02

ENZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Affymetrix Inc $8.53 USD +0.17
Computer Programs & Systems Inc $59.11 USD -1.06
HealthStream Inc $25.50 USD +0.05
Luminex Corp $19.93 USD +0.31
Merge Healthcare Inc $2.41 USD -0.08
View Industry Companies
 

Industry Analysis

ENZ

Industry Average

Valuation ENZ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.6x
Price/Book 6.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit www.enzo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.